CHEMM 📈 ChemoMetec - Overview
Exchange: CO • Country: Denmark • Currency: DKK • Type: Common Stock • ISIN: DK0060055861
CHEMM: Cell Counters, Analyzers, Cytometers, Consumables, Accessories
ChemoMetec A/S is a company that specializes in the development, production, and sale of analytical equipment for cell counting and analysis, with a global presence spanning the United States, Canada, Europe, and international markets. The company's solutions cater to a diverse range of applications, including cell and gene therapy, cancer and stem cell research, and the development and manufacturing of pharmaceuticals. Additionally, their products are used in the production and quality control of animal semen, milk, and beer, highlighting the versatility of their technology.
The company's product portfolio includes a range of advanced analytical instruments, such as the NucleoCounter NC-3000, an image cytometer that provides high-resolution cell imaging and analysis. Other notable products include the NucleoCounter NC-250, an automated cell analyzer, and the NucleoCounter NC-202, a consistent cell counter that ensures accurate and reliable results. The NucleoCounter NC-200 is another key product, offering an automated solution for cell counting and cell viability determination. Furthermore, the company offers specialized products like the NucleoCounter SP-100, an automated sperm cell counter designed for use in animal reproduction, and the XcytoMatic 40, a cell density and viability analyzer that provides comprehensive insights into cell health and behavior.
In addition to its analytical instruments, ChemoMetec A/S also provides a range of consumables and accessories to support its products. These include cassettes, reagents, lysis, and slides, as well as cables, power supplies, software, and labware products. The company also offers service and validation plans, as well as training programs, to ensure that customers can optimize the use of their products and achieve the best possible results. Moreover, the company is continuously developing new products, such as the XcytoMatic 30 cell counter, which underscores its commitment to innovation and customer satisfaction. With its headquarters in Allerød, Denmark, and a history dating back to 1997, ChemoMetec A/S has established itself as a trusted partner in the life sciences industry.
As a publicly traded company, ChemoMetec A/S is listed under the ISIN code DK0060055861, with its common stock classified under the GICS Sub Industry of Life Sciences Tools & Services. The company's website, https://chemometec.com, provides further information on its products, services, and mission to deliver innovative solutions for cell counting and analysis. By leveraging its expertise and technology, ChemoMetec A/S aims to support advancements in various fields, from pharmaceutical development to animal reproduction, and contribute to the progress of the life sciences industry as a whole.
Additional Sources for CHEMM Stock
CHEMM Stock Overview
Market Cap in USD | 1,166m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 2006-12-18 |
CHEMM Stock Ratings
Growth 5y | 34.8% |
Fundamental | 70.9% |
Dividend | 7.66% |
Rel. Strength Industry | 605 |
Analysts | - |
Fair Price Momentum | 440.85 DKK |
Fair Price DCF | 140.46 DKK |
CHEMM Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 25.5% |
CHEMM Growth Ratios
Growth Correlation 3m | 83.1% |
Growth Correlation 12m | 24.7% |
Growth Correlation 5y | -7.3% |
CAGR 5y | 18.66% |
CAGR/Mean DD 5y | 0.53 |
Sharpe Ratio 12m | 0.59 |
Alpha | -6.34 |
Beta | 1.24 |
Volatility | 53.02% |
Current Volume | 79.3k |
Average Volume 20d | 40.6k |
As of December 21, 2024, the stock is trading at DKK 491.00 with a total of 79,262 shares traded.
Over the past week, the price has changed by -0.12%, over one month by +13.68%, over three months by +15.01% and over the past year by +16.43%.
Yes, based on ValueRay Fundamental Analyses, ChemoMetec (CO:CHEMM) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 70.89 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CHEMM as of December 2024 is 440.85. This means that CHEMM is currently overvalued and has a potential downside of -10.21%.
ChemoMetec has no consensus analysts rating.
According to ValueRays Forecast Model, CHEMM ChemoMetec will be worth about 494 in December 2025. The stock is currently trading at 491.00. This means that the stock has a potential upside of +0.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 545 | 11% |
Analysts Target Price | - | - |
ValueRay Target Price | 494 | 0.6% |